177 related articles for article (PubMed ID: 35616981)
1. Prospective Evaluation of Taste Function in Patients With Head and Neck Cancer Receiving Intensity-Modulated Radiotherapy.
Chen WC; Hsu CM; Tsai YT; Lin MH; Tsai MS; Chang GH; Lai CH; Fang F; Chen MF
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):604-611. PubMed ID: 35616981
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Taste Impairment after Intensity-Modulated Radiotherapy to Treat Head-and-Neck Cancer: Correlations with Glossectomy and the Mean Radiation Dose to the Oral Cavity.
Chen WC; Tsai MS; Tsai YT; Lai CH; Lee CP; Chen MF
Chem Senses; 2019 May; 44(5):319-326. PubMed ID: 30957861
[TBL] [Abstract][Full Text] [Related]
3. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
4. The effect of radiotherapy on taste sensation in head and neck cancer patients - a prospective study.
Asif M; Moore A; Yarom N; Popovtzer A
Radiat Oncol; 2020 Jun; 15(1):144. PubMed ID: 32503643
[TBL] [Abstract][Full Text] [Related]
5. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.
Tribius S; Raguse M; Voigt C; Münscher A; Gröbe A; Petersen C; Krüll A; Bergelt C; Singer S
Strahlenther Onkol; 2015 Jun; 191(6):501-10. PubMed ID: 25747264
[TBL] [Abstract][Full Text] [Related]
6. Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer.
Iovoli AJ; Turecki L; Qiu ML; Khan M; Smith K; Yu H; Ma SJ; Farrugia MK; Singh AK
JAMA Netw Open; 2023 Oct; 6(10):e2337265. PubMed ID: 37819659
[TBL] [Abstract][Full Text] [Related]
7. De Gustibus: time scale of loss and recovery of tastes caused by radiotherapy.
Maes A; Huygh I; Weltens C; Vandevelde G; Delaere P; Evers G; Van den Bogaert W
Radiother Oncol; 2002 May; 63(2):195-201. PubMed ID: 12063009
[TBL] [Abstract][Full Text] [Related]
8. The effect of glutamine and arginine-enriched nutritional support on quality of life in head and neck cancer patients treated with IMRT.
Yuce Sari S; Yazici G; Yuce D; Karabulut E; Cengiz M; Ozyigit G
Clin Nutr ESPEN; 2016 Dec; 16():30-35. PubMed ID: 28531452
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
[TBL] [Abstract][Full Text] [Related]
10. Objective and subjective assessment of xerostomia in patients of locally advanced head-and-neck cancers treated by intensity-modulated radiotherapy.
Lal P; Nautiyal V; Verma M; Yadav R; Maria Das KJ; Kumar S
J Cancer Res Ther; 2018; 14(6):1196-1201. PubMed ID: 30488829
[TBL] [Abstract][Full Text] [Related]
11. Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.
Tribius S; Haladyn S; Hanken H; Busch CJ; Krüll A; Petersen C; Bergelt C
Strahlenther Onkol; 2021 Mar; 197(3):219-230. PubMed ID: 33377992
[TBL] [Abstract][Full Text] [Related]
12. Comparison three-dimensional conformal radiotherapy versus intensity modulated radiation therapy in local control of head and neck cancer.
Ghosh G; Gupta G; Malviya A; Saroj D
J Cancer Res Ther; 2018; 14(6):1412-1417. PubMed ID: 30488865
[TBL] [Abstract][Full Text] [Related]
13. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483
[TBL] [Abstract][Full Text] [Related]
14. Taste alteration and impact on quality of life after head and neck radiotherapy.
Baharvand M; ShoalehSaadi N; Barakian R; Moghaddam EJ
J Oral Pathol Med; 2013 Jan; 42(1):106-12. PubMed ID: 22862149
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy-induced taste impairment.
Ruo Redda MG; Allis S
Cancer Treat Rev; 2006 Nov; 32(7):541-7. PubMed ID: 16887272
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03.
Toledano I; Graff P; Serre A; Boisselier P; Bensadoun RJ; Ortholan C; Pommier P; Racadot S; Calais G; Alfonsi M; Favrel V; Giraud P; Lapeyre M
Radiother Oncol; 2012 Apr; 103(1):57-62. PubMed ID: 22296746
[TBL] [Abstract][Full Text] [Related]
17. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience.
Van Gestel D; Van Den Weyngaert D; Schrijvers D; Weyler J; Vermorken JB
Br J Radiol; 2011 Apr; 84(1000):367-74. PubMed ID: 21415302
[TBL] [Abstract][Full Text] [Related]
19. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.
Lin A; Kim HM; Terrell JE; Dawson LA; Ship JA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):61-70. PubMed ID: 12909216
[TBL] [Abstract][Full Text] [Related]
20. Taste dysfunction in patients receiving radiotherapy.
Yamashita H; Nakagawa K; Tago M; Nakamura N; Shiraishi K; Eda M; Nakata H; Nagamatsu N; Yokoyama R; Onimura M; Ohtomo K
Head Neck; 2006 Jun; 28(6):508-16. PubMed ID: 16619275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
